Ben Saida Imen, Chebil Dhekra, Jomaa Wassim, Zghidi Marwa, Attia Khalil, Boussarsar Mohamed
Faculty of Medicine of Sousse, Farhat Hached University Hospital, Medical Intensive Care Unit, Research Laboratory LR12SP09 "Heart Failure", University of Sousse, Sousse, Tunisia.
Preventive Medicine Department, Ibn Al Jazzar University Hospital, Research Laboratory LR19SP01, "Measurement and Support for the Performance of Healthcare Establishments", Faculty of Medicine of Sousse, University of Sousse, Kairouan, Tunisia.
PLoS One. 2025 Jul 23;20(7):e0328558. doi: 10.1371/journal.pone.0328558. eCollection 2025.
Noninvasive ventilation (NIV) is a cornerstone in the management of Acute Exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD). The aim of this study is to assess the impact of music-based intervention on the efficiency of NIV in patients with AECOPD.
It's a prospective, randomized, single-blinded, parallel-group trial. Critically ill COPD patients admitted for acute exacerbation and eligible for NIV will be included. Patients in the control group will receive only NIV. In the intervention group, patients will receive NIV with music-based intervention. The music will be delivered through headphones. Both groups will receive standard care in accordance with current clinical guidelines. The primary endpoint is the change in arterial Pressure of Carbon dioxide PaCO2, defined as the difference between baseline PaCO₂ (prior to NIV initiation) and PaCO₂ measured after 4 hours. Secondary endpoints will be recorded at different time points: change of PaCO2 over time (h0, h2, h4), unplanned interventions, changes in respiratory and cardiovascular parameters (h0, h2, h4), changes in Respiratory comfort (h0, h2, h4), Borg Dyspnea Scale (h0, h2, h4), Verbal Numeric Rating Scale for pain assessment (h0, h2, h4), Encephalopathy score (h0, h2, h4), Richmond Agitation-Sedation Scale (h0, h2, h4), and psychological assessment (Rapid Clinical Test For delirium, State Trait Anxiety Inventory, perceived stress scale) (h0, h4).
This study is expected to contribute reliable scientific evidence for the optimal management of AECOPD, potentially reducing the need for intubation and mechanical ventilation and their associated complications.
The study was prospectively registered on the Pan African Clinical Trial Registry within the number PACTR202501862862010.
无创通气(NIV)是慢性阻塞性肺疾病急性加重(AECOPD)管理的基石。本研究的目的是评估基于音乐的干预对AECOPD患者无创通气效率的影响。
这是一项前瞻性、随机、单盲、平行组试验。将纳入因急性加重入院且符合无创通气条件的重症慢性阻塞性肺疾病患者。对照组患者仅接受无创通气。干预组患者将接受无创通气并进行基于音乐的干预。音乐将通过耳机播放。两组均将按照当前临床指南接受标准护理。主要终点是动脉血二氧化碳分压(PaCO2)的变化,定义为基线PaCO₂(无创通气开始前)与4小时后测量的PaCO₂之间的差值。次要终点将在不同时间点记录:PaCO2随时间的变化(h0、h2、h4)、非计划干预、呼吸和心血管参数的变化(h0、h2、h4)、呼吸舒适度的变化(h0、h2、h4)、博格呼吸困难量表(h0、h2、h4)、疼痛评估的言语数字评定量表(h0、h2、h4)、脑病评分(h0、h2、h4)、里士满躁动-镇静量表(h0、h2、h4)以及心理评估(谵妄快速临床测试、状态特质焦虑量表、感知压力量表)(h0、h4)。
本研究有望为AECOPD的最佳管理提供可靠的科学证据,可能减少插管和机械通气的需求及其相关并发症。
该研究已在泛非临床试验注册中心进行前瞻性注册,注册号为PACTR202501862862010。